Supply Chain Issues Hit Neogen's Q4 Margins, Earnings

  • Neogen Corporation NEOG reported a Q4 net income of $0.15 per share, missing a consensus estimate of $0.16 
  • Q4 Revenues increased 17% Y/Y to $127.4 million ahead of the analysts' estimate of $122.3 million.
  • Gross margins decreased to 45.3% from 47.4% a year ago, attributable to higher supply chain costs and personnel costs. 
  • The operating margin also decreased from 18.3% in Q4 of 2020 to 15.9%.
  • Revenues for the Food Safety segment were $64.1 million, +18% Y/Y. Organic growth for the segment was 12%, with Megazyme providing most of the acquisition revenue.
  • The segment also benefitted as businesses rebound from the COVID-19 pandemic, with sales of natural toxin (10%) and allergen (19%) test kits increasing.
  • The Animal Safety segment reported revenues of $63.3 million, up 16% Y/Y driven by solid growth in the veterinary instruments line (50%) and animal care line (51%) of antibiotics. 
  • Price Action: NEOG shares are down 0.8% at $43.87 during the premarket session on the last check Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsHealth CareGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!